Tailored adherence program to help adolescents and young adults with cancer take their medications
Official title: A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults with Cancer
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11401179 · Data updated 2026-11-12
A personalized program called SUMMIT helps teens and young adults with cancer take their prescribed medications more reliably to improve outcomes.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | September 1, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $672,904 |
| NIH project number | 5R37CA302422-02 |
| Project ID | NIH-11401179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents and young adults with cancer who are on prescribed cancer medications and have adherence challenges.
✕Less likely to help
AYAs who do not have adherence difficulties or who are not on a cancer medication may not benefit.
What this research studies
Many AYAs with cancer struggle to stay on their medication plans, which can lead to worse health results. This grant tests a personalized, behavior-change based approach (SUMMIT) designed specifically for AYAs to tackle individual barriers like forgetfulness and motivation. The study compares SUMMIT to standard care in a randomized trial to see if it improves medication adherence. It builds on prior pilot data showing the approach is feasible, acceptable, and usable for this population. If effective, SUMMIT could become a tailored option to support adherence and potentially improve survival for AYAs with cancer.
Why it matters
Potential benefit: If successful, this program could help more AYAs adhere to their cancer medicines, improving treatment outcomes and quality of life.
How similar studies have gone: Preliminary pilot data suggest feasibility and usability of a tailored adherence intervention in this population.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Mcgrady, Meghan Eileen — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Mcgrady, Meghan Eileen
Related research
Other NIH-funded projects on the same topics.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Incentives and Anchoring to Improve Long-term HIV Medication Adherence
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
-
WeCare: a combined mental health and HIV medication support program for high-risk men
A patient-friendly program called WeCare aims to support mental health and improve adherence to HIV meds among high-risk men in settings with limited resources.
-
Medication adherence to epilepsy medicines during pregnancy and related birth outcomes
This project looks at how well pregnant people with epilepsy take their anti-seizure medicines and what happens to their babies.
-
Adaptive mHealth Support to Help Teens with Asthma Stick to Their Inhalers
A multi-site study tests a flexible smartphone-based program to help adolescents with asthma take their inhaled meds more consistently.
-
Reducing High Blood Pressure in Men in Manual Jobs with a Mobile Stress and Medication Adherence Program
A mobile stress-management and medication adherence program aims to help men in manual and trade jobs lower their blood pressure and stay on their prescribed treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.